Inflammatory Disorders
📧 Sign up to get email alerts when something new happens for Inflammatory Disorders.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2022-11-11EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
The EMA confirms risk-minimising measures for Janus kinase inhibitors used in chronic inflammatory disorders to address serious side effects…
-
EMA guidance · 2022-10-28EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
EMA recommends measures to minimize serious side effects associated with Janus kinase inhibitors used for chronic inflammatory disorders.